30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Parabilis Medicines Inc (PBLS)

Track

Over the last 90 days, Parabilis Medicines Inc. has seen significant insider buying activity, with a total buy value of $424,498,528.54. Two insiders were net buyers, with RA Capital Management, L.P. and SEBULSKY ALAN making substantial purchases. No insider selling was reported during this period.
Stock chart
Ticker: PBLS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SEBULSKY ALAN
2 purchases — total 200,000 USD
Buy 15 Jun 2026
Value US$4,269,169.14 | Price 240.06 | Shares 19,960
Buy 15 Jun 2026
Value US$2,059,164.58 | Price 496.52 | Shares 17,993
Buy 12 Jun 2026
Value US$2,279,550.46 | Price 244.91 | Shares 61,177
Buy 11 Jun 2026
Value US$100,000.00 | Price 20.00 | Shares 1,000
Buy 11 Jun 2026
Value US$100,000.00 | Price 20.00 | Shares 1,000
Buy 11 Jun 2026
Value US$100,000.00 | Price 20.00 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-15 B Purchase
SEBULSKY ALAN
Non-Executive Director
19,960 +11.5%
240.06
US$4,269,169 		19,960 +11.5% 240.06 US$4,269,169
2026-06-16 2026-06-15 B Purchase
SEBULSKY ALAN
Non-Executive Director
17,993 -31.6%
496.52
US$2,059,165 		17,993 -31.6% 496.52 US$2,059,165
2026-06-16 2026-06-12 B Purchase
SEBULSKY ALAN
Non-Executive Director
61,177 -38.3%
244.91
US$2,279,550 		61,177 -38.3% 244.91 US$2,279,550
2026-06-15 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +122.9%
20.00
US$100,000 		1,000 +122.9% 20.00 US$100,000
2026-06-15 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +300.9%
20.00
US$100,000 		1,000 +300.9% 20.00 US$100,000
2026-06-15 2026-06-11 B Purchase
SEBULSKY ALAN
Non-Executive Director
1,000 +inf%
20.00
US$100,000 		1,000 +inf% 20.00 US$100,000
Explore more

More insider trading research around Parabilis Medicines Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America